Cladribine

Red

Brand Name(s):Leustat, Litak

Indication:Hairy cell leukaemia

Rationale:1,2,3

Considered:Oct-09

Review Date:Nov-22

Comments:
Drug Safety Update
Cladribine (Litak, Leustat) for leukaemia: reports of progressive multifocal encephalopathy (PML); stop treatment if PML suspected
Dec 2017